Henry A. Nasrallah, MD

Article

Introduction. Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond

January 15, 2007

Henry A. Nasrallah

Article

An Overview of Common Medical Comorbidities in Patients With Schizophrenia

August 15, 2005

Henry A. Nasrallah

Article

Neurologic Comorbidities in Schizophrenia

August 15, 2005

Henry A. Nasrallah

Academic Highlights

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

January 15, 2005

Rajiv Tandon, Peter J. Weiden, John M. Kane, et al

Original Research

Risperidone in the Treatment of Delirium: Results From a Prospective Open-Label Trial

May 1, 2004

Henry A. Nasrallah, Dinesh Mittal, Nita A. Jimerson, et al

Original Research

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

April 1, 2004

Henry A. Nasrallah, Inge Duchesne, Angelika Mehnert, et al

Academic Highlights

Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.

January 1, 2004

Robert R. Conley, John M. Kane, Henry A. Nasrallah, et al

Article

Treatment of Bipolar Disorder

May 1, 2003

Hans-Jürgen Möller, Henry A. Nasrallah

Article

Efficacy, Safety, and Tolerability of Quetiapine in Patients With Schizophrenia

December 31, 2002

Rajiv Tandon, Henry A. Nasrallah

Original Research

Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes: Findings From a Large Health Plan Database

October 1, 2002

Ramy A. Mahmoud, Henry A. Nasrallah, Frank D. Gianfrancesco, et al

Book Review

In Search of Madness: Schizophrenia and Neuroscience

September 23, 2002

Henry A. Nasrallah

Introduction. Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond

An Overview of Common Medical Comorbidities in Patients With Schizophrenia

Neurologic Comorbidities in Schizophrenia

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

Risperidone in the Treatment of Delirium: Results From a Prospective Open-Label Trial

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.

Treatment of Bipolar Disorder

Efficacy, Safety, and Tolerability of Quetiapine in Patients With Schizophrenia

Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes: Findings From a Large Health Plan Database

In Search of Madness: Schizophrenia and Neuroscience

ELSEWHERE:

FOLLOW US:

Henry A. Nasrallah, MD

Introduction. Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond

An Overview of Common Medical Comorbidities in Patients With Schizophrenia

Neurologic Comorbidities in Schizophrenia

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

Risperidone in the Treatment of Delirium: Results From a Prospective Open-Label Trial

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.

Treatment of Bipolar Disorder

Efficacy, Safety, and Tolerability of Quetiapine in Patients With Schizophrenia

Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes: Findings From a Large Health Plan Database

In Search of Madness: Schizophrenia and Neuroscience

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles